Mycobacteriophage D29 Lysin B exhibits promising anti-mycobacterial activity against drug-resistant .

To combat the rapidly emerging drug-resistant , it is now essential to look for alternative therapeutics. Mycobacteriophages can be considered as efficient therapeutics due to their natural ability to infect and kill mycobacteria including . Here, we have exploited the mycolyl-arabinogalactan esterase property of LysB encoded from mycobacteriophage D29.